Department of Ophthalmology.
ICES, Toronto, ON, Canada.
J Glaucoma. 2021 Jun 1;30(6):e300-e304. doi: 10.1097/IJG.0000000000001792.
To evaluate evolution in the distribution of new glaucoma patients between ophthalmologists and optometrists, and to examine factors predicting provider type, in the context of expansion in the scope of optometry practice.
A population-based study was undertaken using validated datasets in Ontario, Canada from 2007 to 2018, encompassing time before and after optometry practice scope expansion in 2011. All patients aged 66 and older receiving a glaucoma suspect diagnosis or first-line therapy for glaucoma from ophthalmologists or optometrists were enrolled. Predictors of provider type were evaluated using logistic regression.
From 2007 to 2018, 401,560 patients received initial glaucoma care, including 303,440 by ophthalmologists and 98,120 by optometrists. Population rates of glaucoma suspect diagnosis increased for both providers over the study period. The rate of therapy initiation increased annually among optometrists after 2011, while the rate remained stable over that period among ophthalmologists. By 2018, 88% of patients initiating therapy and 59% of patients first diagnosed as a glaucoma suspect received that care from ophthalmologists. In the final study year, therapy initiations per provider were lower among optometrists (median: 2/provider; interquartile range: 1 to 3) than among ophthalmologists (median: 26.5/provider, interquartile range: 10 to 53). Patients were more likely to receive care from an ophthalmologist than an optometrist if they were older, had higher ocular or systemic comorbidity, or lived in urban settings.
Optometrists have a large and growing role in diagnosing glaucoma suspects; however, despite scope expansion, optometrists play a much smaller role in initiating glaucoma therapy.
评估在验光师实践范围扩大的背景下,眼科医生和验光师之间新的青光眼患者分布的变化,并研究预测提供者类型的因素。
本研究采用加拿大安大略省的基于人群的验证数据集,时间范围为 2007 年至 2018 年,包括 2011 年验光师实践范围扩大之前和之后的时间。所有年龄在 66 岁及以上、从眼科医生或验光师处获得青光眼疑似诊断或一线青光眼治疗的患者均纳入本研究。使用逻辑回归评估提供者类型的预测因素。
2007 年至 2018 年,有 401560 名患者接受了初始青光眼治疗,其中 303440 名患者由眼科医生治疗,98120 名患者由验光师治疗。在研究期间,两种提供者的青光眼疑似诊断率均有所上升。2011 年后,验光师的治疗开始率逐年增加,而同期眼科医生的治疗开始率保持稳定。到 2018 年,88%开始治疗的患者和 59%首次被诊断为青光眼疑似的患者都接受了眼科医生的治疗。在研究的最后一年,每个验光师的治疗启动量(中位数:2/提供者;四分位间距:1 至 3)低于眼科医生(中位数:26.5/提供者,四分位间距:10 至 53)。如果患者年龄较大、患有更高的眼部或全身合并症,或居住在城市地区,他们更有可能从眼科医生那里获得治疗,而不是从验光师那里获得治疗。
验光师在诊断青光眼疑似患者方面发挥着重要且不断增长的作用;然而,尽管实践范围扩大,验光师在开始青光眼治疗方面的作用要小得多。